v3.26.1
Basis of presentation
12 Months Ended
Dec. 31, 2025
Basis of presentation  
Basis of presentation

Note 3.Basis of presentation

The consolidated financial statements are prepared in accordance with the Generally Accepted Accounting Principles in the United States of America (“US GAAP”) as set forth in the Financial Accounting Standards Board’s (FASB) Accounting Standards Codification (ASC). All amounts are in United States dollars (“USD”) unless otherwise stated.

Acquisition of IC’Alps

On August 4, 2025, SEALSQ acquired 100% of the issued and outstanding shares of IC’Alps SAS (“IC’Alps”), a French société par actions simplifiée, pursuant to a Share Purchase Agreement dated May 26, 2025. IC’Alps is a France-based ASIC and system-on-chip design company serving the medical, automotive, industrial and security markets.

The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations, with SEALSQ identified as the accounting acquirer. The assets, liabilities and results of IC’Alps have been included in the Group’s consolidated financial statements from August 4, 2025 (see Note 6).

The acquisition enhances SEALSQ’s semiconductor design capabilities and expands its engineering workforce and customer relationships.

Additional paid-in capital

During our 2025 financial reporting process, we ascertained that, although SEALSQ is a BVI company with a direct listing on a U.S. stock exchange, its tax residency status means that it is liable for stamp duties in Switzerland for its share issues. This resulted in the Group not accruing for stamp duties on its share issues since inception, which affected SEALSQ’s equity presentation of capital increases in the financial statements ended December 31, 2024 and 2023. The error resulted in an overstatement of the capital increase impacts in additional paid-in capital and an understatement of other current liabilities. We assessed that there was not a substantial likelihood that the error would have been viewed by the reasonable investor as having significantly altered the “total mix” of information made available, and as such concluded that a “little r” restatement was required. In application of ASC 250, we corrected the error in the current year comparative financial statements by adjusting the prior period information.

The tables below show the effect of the adjustment of the prior period information on the Consolidated Balance Sheets, Consolidated Statements of Changes in Shareholders’ Equity and Consolidated Statements of Cash Flows. The related interest accrual in relation to the late payment in prior years was deemed immaterial and was not adjusted in retained earnings, instead, a total cumulated interest expense of $86,474 was recorded in the income statement in the year ended December 31, 2025 ($4,884 arising in 2023, $14,563 in 2024 and $67,028 in 2025).

Consolidated Balance Sheets

As at December 31, 2024

As reported in the financial statements

As adjusted in the financial statements 

USD’000, except par value

  ​ ​ ​

ended December 31, 2024

  ​ ​ ​

ended December 31, 2025

Other current liabilities

 

283

 

1,659

Total current liabilities

 

15,517

 

16,893

TOTAL LIABILITIES

 

19,702

 

21,078

SHAREHOLDERS’ EQUITY

 

 

Additional paid-in capital

 

117,944

 

116,568

Total shareholders’ equity

 

77,864

 

76,488

TOTAL LIABILITIES AND EQUITY

 

97,566

 

97,566

Consolidated Statements of Changes in Shareholders’ Equity

As reported in the financial statements

As adjusted in the financial statements

ended December 31, 2024

ended December 31, 2025

  ​ ​ ​

Additional

  ​ ​ ​

  ​ ​ ​

Additional

  ​ ​ ​

USD’000

paid-in capital

Total equity

paid-in capital

Total equity

As at December 31, 2023

 

24,730

 

5,031

 

24,435

 

4,736

Share Purchase Agreements

 

75,554

 

76,302

 

74,674

 

75,422

Warrant exercises

 

17,512

 

17,610

 

17,311

 

17,409

As at December 31, 2024

 

117,944

 

77,864

 

116,568

 

76,488

Consolidated Statements of Cash Flows

As reported in the financial 

As adjusted in the financial 

statements ended December 31, 2024

statements ended December 31, 2025

12 months ended December 31,

12 months ended December 31,

USD’000

  ​ ​ ​

2024

  ​ ​ ​

2023

  ​ ​ ​

2024

  ​ ​ ​

2023

Cash Flows from operating activities:

 

  ​

 

  ​

 

  ​

 

  ​

Increase / (decrease) in other current liabilities, excluding stock-based compensation liability

 

145

 

(10)

 

1,226

 

285

Net cash provided by / (used in) operating activities

 

(11,205)

 

(3,040)

 

(10,124)

 

(2,745)

Cash Flows from financing activities:

 

  ​

 

  ​

 

  ​

 

  ​

Common Stock issuance costs

 

(4,855)

 

 

(5,936)

 

(295)

Net cash provided by / (used in) financing activities

 

89,481

 

8,920

 

88,400

 

8,625